Melvin Jose

Melvin Jose is an accomplished Strategic Account Development Manager at Cell Signaling Technology, specializing in the Biopharma sector across the EMEA region since January 2020. With a strong track record in exceeding sales targets, Melvin expertly manages both direct markets in the UK and DACH while supporting growth in hybrid commercial roles. Previous roles include Key Account Manager for the UK, where consistent year-over-year growth and strategic planning were key achievements, and Senior Account Manager at Proteintech Group, where management of key accounts in the UK and globally was a focus. Melvin's expertise spans account management, strategic planning, and business development in the pharmaceutical, biotechnology, and academic sectors, underpinned by an MSc in Biotechnology, Bioprocessing, and Business Management from the University of Warwick. Additionally, Melvin has contributed articles to notable journals and has a robust background in research and development within life sciences.